Matches in Wikidata for { <http://www.wikidata.org/entity/Q62025724> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q62025724 description "clinical trial" @default.
- Q62025724 description "ensayo clínico" @default.
- Q62025724 description "ensayu clínicu" @default.
- Q62025724 description "klinisch onderzoek" @default.
- Q62025724 description "клінічне випробування" @default.
- Q62025724 description "临床试验" @default.
- Q62025724 name "A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM" @default.
- Q62025724 type Item @default.
- Q62025724 label "A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM" @default.
- Q62025724 prefLabel "A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM" @default.
- Q62025724 P1050 Q62025724-9F82FC2A-0C49-47D7-91F8-9E6D38CF832C @default.
- Q62025724 P1132 Q62025724-596690C5-5957-4624-81B6-BB388CC6F187 @default.
- Q62025724 P1476 Q62025724-86D8FE8C-4BEF-4FFD-9577-CDD9478C3E82 @default.
- Q62025724 P17 Q62025724-B97BEF96-BBA0-4FDF-9404-708EFC1CCAC7 @default.
- Q62025724 P2899 Q62025724-1C788283-C6B6-4992-B7F4-D48FA7B9C4B3 @default.
- Q62025724 P3098 Q62025724-D8659261-8462-4265-80C3-60052FCBE672 @default.
- Q62025724 P31 Q62025724-72603735-98D9-413F-A93B-D65564168162 @default.
- Q62025724 P4135 Q62025724-453E11C9-B4D3-472C-9EC7-93BE6983A2A1 @default.
- Q62025724 P4844 Q62025724-74C4E284-B9C3-4C56-B566-DE87B4D0513A @default.
- Q62025724 P580 Q62025724-65C50C5E-77FE-4A67-8D4C-E33833753899 @default.
- Q62025724 P582 Q62025724-3A3E1293-001F-4605-843C-3843754F3425 @default.
- Q62025724 P6099 Q62025724-7B327793-0BCF-4C96-A6D2-BC61B9EA5DCD @default.
- Q62025724 P6153 Q62025724-331B3B7B-802C-46CE-9746-60C5535E7137 @default.
- Q62025724 P6153 Q62025724-C16919F6-C66D-4646-A3A8-8A4DC6E7F8E1 @default.
- Q62025724 P8005 Q62025724-754AE0C9-ABE6-4E75-B3D7-263FF93F5D89 @default.
- Q62025724 P8363 Q62025724-F10DDBAE-1E94-495A-9641-3A370513684B @default.
- Q62025724 P1050 Q12206 @default.
- Q62025724 P1132 "+99" @default.
- Q62025724 P1476 "A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM" @default.
- Q62025724 P17 Q30 @default.
- Q62025724 P2899 "+18" @default.
- Q62025724 P3098 "NCT03646721" @default.
- Q62025724 P31 Q30612 @default.
- Q62025724 P4135 "+70" @default.
- Q62025724 P4844 Q27259224 @default.
- Q62025724 P580 "2018-08-29T00:00:00Z" @default.
- Q62025724 P582 "2019-10-07T00:00:00Z" @default.
- Q62025724 P6099 Q5452194 @default.
- Q62025724 P6153 Q30270305 @default.
- Q62025724 P6153 Q50036548 @default.
- Q62025724 P8005 Q76649708 @default.
- Q62025724 P8363 Q78089383 @default.